- Q1 2 %66.7
- Q2 1 %33.3
- Q3 0 %0.0
- Q4 0 %0.0
Academician
RIFAT RASİER
Profesör
İstinye Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Bölümü
Research topics OpenAlex
- Retinal Diseases and Treatments4
- Retinal Imaging and Analysis3
- Retinal and Optic Conditions2
- Inflammatory Biomarkers in Disease Prognosis1
- Ion Channels and Receptors1
- Ocular Surface and Contact Lens1
- Allergic Rhinitis and Sensitization1
- Ophthalmology and Visual Impairment Studies1
- Retinal Development and Disorders1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Göz Hastalıkları
Academic summary
YÖKSİS and OpenAlex counted separately.
Articles
42
YÖKSİS42
OpenAlex0
Projects
3
Books
3
Proceedings
103
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 4 + YÖKSİS · co-author record: 21
h-index
14
Percentile in Türkiye: 43
#283 of 516 at their university by h-index
- i10-index
- 17
- Total citations
- 603 Top 43% in Türkiye
- Per article
- 24.1
- FWCI
- 1.63 1.00 = world average
- World top 1%
- 0
- World top 10%
- 2
Most cited articles
- Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study
- Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection
- The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 21 articles (538 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #20,465/ 39,749 top 51.5% At university #169/ 363Score 10.6 journal 10.6 · OA add 0
- Article rank11,149/39,749
- Scopus rank27,112/39,749
- WoS rank26,912/39,749
- YÖKSİS42
- Scopus3
- WoS3
-
Side field Göz HastalıklarıPoints rank #435/ 658 top 66.1% At university #4/ 5Score 10.6 journal 10.6 · OA add 0
- Article rank252/658
- Scopus rank507/658
- WoS rank506/658
- YÖKSİS42
- Scopus3
- WoS3
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 32
- With an akaturk profile
- 4
- Turkish institutions
- 2
- Co-authored works
- %100
Academic co-authors 4
- ELVAN ALPER ŞENGÜL Profesör · Demiroğlu Bilim Üniversitesi 4
- HALİL ÖZGÜR ARTUNAY Profesör · Sağlık Bilimleri Üniversitesi 3
- VEYSEL SABRİ HANÇER Profesör · İstinye Üniversitesi same university 1
- ÇAVLAN ÇİFTÇİ Profesör · Demiroğlu Bilim Üniversitesi 1
National collaboration 2 institutions
Within own university1 joint works · İstinye Üniversitesi
- Demiroğlu Bilim Üniversitesi 4 works · 2 academics
- Sağlık Bilimleri Üniversitesi 3 works · 1 academics
Other co-authors (incl. international) 28
Artunay Özgür 37ERDAL YÜZBAŞIOĞLU 37Bahçecioğlu Halil. 29Şengül Alper 26Bahçecioğlu H. 8Sengul A 8Şenel Amber 7ALEV KOÇKAR 3Ceyda Afacan 2MURAT GÜLSOY 2Mustafa Unal 2NAZLI GÜL YALÇIN 2Oncel Murat 2Senel Kukner Amber 2Uzay Görmüş 2Adnan KurtAlphan SennarogluBahçecioğluBahçecioğlu Halil ÖnderHamit KalaycıogluIsmail SeckinMediha OzerenNilgün Güdücü.ONUR TEMİZSOYLUPALMET GÜN ATAKSarici AUtine Canan AslıÖncel Banu
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Index quartiles
?- Q1 0 %0.0
- Q2 2 %66.7
- Q3 0 %0.0
- Q4 1 %33.3
Top 1%0
Top 10%0
Avg · n 5
%74.2
Other counts
Scopus (SJR)
- YÖKSİS rows 4
WoS (JCR)
- YÖKSİS rows 4
Projects
Research and development projects recorded in YÖKSİS.
Records
-
— Comparison of safety, effectiveness and quality of life outcomes between labeled versus ’treat and extend’ regimen in Turkish patients with choroidal neovascularisation due to AMD (SALUTE)
-
— LUMINOUS Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes
-
— Katarakt ameliyatlarında kullanılmak üzere lazerle kornea doku kaynağı cihazı